Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003873 · ClinicalTrials.gov registry record · Phase 3
Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer
A Phase 3 study, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 3
- Development phase
- 950
- Enrollment target
NCT00003873: Completed Phase 3 study, sponsored by National Cancer Institute (NCI).
NCT00003873 is a Phase 3 study that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 950 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003873, a Phase 3 study, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 950 participants
- Enrollment target
Study Summary
Randomized phase III trial to compare the effectiveness of fluorouracil given by infusion with that of fluorouracil plus eniluracil given by mouth in treating patients who have metastatic, recurrent, or residual advanced colorectal cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if fluorouracil is more effective with or without eniluracil for advanced colorectal cancer
Interventions
- DRUG fluorouracil
- DRUG eniluracil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 950 participants |
| Start Date | 1999-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003873
The ClinicalTrials.gov registry entry for NCT00003873 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 950 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which fluorouracil is the first listed.
NCT00003873 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003873 about?
NCT00003873 is a clinical study titled "Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer". Randomized phase III trial to compare the effectiveness of fluorouracil given by infusion with that of fluorouracil plus eniluracil given by mouth in treating patients who have metastatic, recurrent, or residual advanced colorectal cancer. Drugs used in chemotherapy use different ways to stop tumor ...
What is the current status of trial NCT00003873?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 950 participants. The study started on 1999-04.
What interventions are being tested in trial NCT00003873?
The interventions under investigation include: fluorouracil (DRUG), eniluracil (DRUG).
Who is sponsoring clinical trial NCT00003873?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.